Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies

CD4+T Cells Predominate in Cerebrospinal Fluid and Leptomeningeal and Parenchymal Infiltrates in Cerebral Amyloid β–Related Angiitis

(2012) Nico Melzer et al.   ARCHIVES OF NEUROLOGY

Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease

(2012) Henrik Zetterberg   ARCHIVES OF NEUROLOGY

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

(2012) Vladimir Coric et al.   ARCHIVES OF NEUROLOGY

Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria

(2012) Dimitri Renard et al.   JOURNAL OF NEUROLOGY

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

(2012) Reisa Sperling et al.   LANCET NEUROLOGY

Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation

(2012) Alessandra Bulbarelli et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy

(2012) M. E. Gurol et al.   NEUROLOGY

Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection

(2012) Lucie Yang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab

(2011) Susanne Ostrowitzki   ARCHIVES OF NEUROLOGY

Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction: case report and review of the literature

(2011) Hideya Sakaguchi et al.   Journal of Neuroinflammation

Anti-A  autoantibodies in the CSF of a patient with CAA-related inflammation: A case report

(2011) J. C. DiFrancesco et al.   NEUROLOGY

Life imitates art: Anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy

(2011) S. M. Greenberg et al.   NEUROLOGY

Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis

(2010) Delphine Boche et al.   ACTA NEUROPATHOLOGICA

Increased Soluble APPα, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients

(2010) Elisa Conti et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Cerebral amyloid angiopathy related inflammation: three case reports and a review

(2010) K. K. Chung et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease

(2010) Fabrizio Piazza et al.   NEUROBIOLOGY OF AGING

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients

(2010) Elisa Conti et al.   NEUROSCIENCE LETTERS

Case 159: Cerebral Amyloid Angiopathy–related Inflammation

(2010) Mario Savoiardo et al.   RADIOLOGY

Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency

(2009) G. Tibolla et al.   ATHEROSCLEROSIS

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

(2009) S. Salloway et al.   NEUROLOGY

Immunotherapy Reduces Vascular Amyloid-  in PDAPP Mice

(2008) S. Schroeter et al.   JOURNAL OF NEUROSCIENCE

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

(2008) Clive Holmes et al.   LANCET